CoChat

Serum free testosterone and metabolic syndrome in Japanese men

Open access
Katabami, Takuyuki, Kato, Hiroyuki, Asahina, Takayuki, Hinohara, Shigeaki, Shin, Tetsuzo, Kawata, Takehiro, Ohta, Akio, Iwamoto, Teruaki, Tanaka, Yasushi · 2010 · Endocrine Journal
Cited by 34

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

To examine the association between late-onset hypogonadism (LOH) and metabolic syndrome (Mets) or insulin resistance in the Japanese adult male population, we evaluated anthropometric parameters, indices of glucose and lipid metabolism, and hormones related to sexual function in 274 men (mean age: 46.0 +/- 11 years) who underwent general health checks. Seventy subjects (25.5%) were diagnosed as having Mets, while the frequency of LOH was 8.0%. Glycated hemoglobin was normal in the majority of participants (94.9%). The serum free testosterone (FT) level was significantly lower in the Mets (+) group than in the Mets (-) group (11.7 +/- 4.0 vs. 14.7 +/- 4.6 pg/mL, p<0.0001). FT decreased significantly along with an increase in the number of Mets components. Likewise, the number of Mets components showed a significant difference among the eugonadal, borderline, and hypogonadal groups (2.2 +/- 1.4, 1.5 +/- 1.4, and 0.9 +/- 1.1, respectively). After adjustment for age, body mass index (BMI), and waist circumference (WC), FT was still significantly correlated with Mets (standard partial regression coefficient = - 0.0971; 95 % confidence interval = - 0.1936 approximately - 0.0006; p = 0.048). A compensatory increase of gonadotropins was not seen in the hypogonadal group. Among Japanese men who were mainly without diabetes, FT was associated with Mets independently of age, BMI, and WC. Mets and insulin resistance may decrease serum testosterone via induction of hypogonadotrophic hypogonadism, and the reduction of testosterone may in turn cause further obesity and insulin resistance, consequently initiating a vicious cycle.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1507/endocrj.k10e-018

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 13

  1. 10.1111/j.1442-2042.2008.02010.x · DOI
  2. 10.1111/j.1442-2042.2008.02203.x · DOI
  3. 10.1111/j.1464-5491.2006.01858.x · DOI · Paper page
  4. 10.1161/CIRCULATIONAHA.105.169404 · DOI · Paper page
  5. 11. Zitzmann M (2009) Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 5: 673-681. · DOI · Paper page
  6. 10.1507/endocrj.K07-077 · DOI · Paper page
  7. 10.1210/jc.84.10.3673 · DOI · Paper page
  8. 17. Bhatia V, Chaudhuri A, Tomar R, Dhindsa S, Ghanim H, Dandona P (2006) Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care 29: 2289-2294. · DOI · Paper page
  9. 10.1210/en.2003-0644 · DOI · Paper page
  10. 10.1046/j.1365-2826.2001.00632.x · DOI · Paper page
  11. 20. Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S (2008) Hypogonadotrophic hypogonadism in type 2 diabetes. Aging Male 11: 107-117. · DOI
  12. 27. Bassil N, Alkaade S, Morley JE (2009) The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag 5: 427-448.
  13. 10.1074/jbc.M414231200 · DOI · Paper page

Cited by

See all 34

Metadata

Authors
Katabami, T., Kato, H., Asahina, T., Hinohara, S., Shin, T., Kawata, T., Ohta, A., Iwamoto, T., & Tanaka, Y.
Venue
Endocrine Journal
Published
2010
Volume
57
Issue
6
Pages
533-539
ISSN
  • 0918-8959 (ISSN-L)
  • 1348-4540
OpenAlex
W2051632430
Cited by
34
References
13
FWCI
3.74
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.